However, GLP-1s can come with challenges, including gastrointestinal side effects, risk of micronutrient deficiencies, muscle and bone loss, poor long-term follow through with weight regain if stopped, and high costs
The relationship between a powerful metabolic agent like Retatrutide and the endocrine system is a delicate dance of cause and effect, direct and indirect actions
A weight loss specialist will help determine the right weight loss medication and plan for you
Retatrutide is not approved for human use in the United Kingdom
Recent clinical reviews have shown that for most patients, starting a GLP-1 medication does not significantly change INR levels
The increase was larger at higher doses, peaked after 24 weeks of treatment, then went down later in the trial